3,926
Views
50
CrossRef citations to date
0
Altmetric
Reviews

Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research

, &
Pages 175-190 | Received 28 Sep 2015, Accepted 25 Nov 2015, Published online: 09 Jan 2016

References

  • Otto W. Versuche und uberledbeudem carcinomgewebe (methoden). Biochemische Zeitschr. 1923;142:317–333.
  • Ha K. Untersuchungen über den Stoffwechsel der Aminosäuren im Tierkörper. Hoppe-Seyl Z. 1933;217:191.
  • Krumdieck CL, Dos Santos J, Ho K-J. A new instrument for the rapid preparation of tissue slices. Anal Biochem. 1980;104(1):118–123.
  • Brendel K, Jay Gandolfi A, Krumdieck CL, et al. Tissue slicing and culturing revisited. Trends Pharmacol Sci. 1987;8(1):11–15.
  • Vickers AE, Fischer V, Connors S, et al. Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines. Drug Metab Dispos. 1992;20(6):802–809.
  • Vickers AE, Fisher RL, Brendel K, et al. Sites of biotransformation for the cyclosporin derivative SDZ IMM 125 using human liver and kidney slices and intestine. Comparison with rat liver slices and cyclosporin A metabolism. Drug Metab Dispos. 1995;23(3):327–333.
  • Smith PF, Gandolfi AJ, Krumdieck CL, et al. Dynamic organ culture of precision liver slices for in vitro toxicology. Life Sci. 1985;36(14):1367–1375.
  • Ruegg CE, Gandolfi AJ, Nagle RB, et al. Preparation of positional renal slices for study of cell-specific toxicity. J Pharmacol Methods. 1987;17(2):111–123.
  • Van De Bovenkamp M, Groothuis GMM, Draaisma AL, et al. Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu. Toxicological Sci. 2005;85(1):632–638.
  • Martignoni M, Groothuis G, De Kanter R. Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Drug Metab Dispos. 2006;34(6):1047–1054.
  • Groothuis GM, de Graaf IA. Precision-cut intestinal slices as in vitro tool for studies on drug metabolism. Curr Drug Metab. 2012;14(1):112–119.
  • Westra IM, Oosterhuis D, Groothuis GMM, et al. The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices. Plos One. 2014;9(4):e95462.
  • Westra IM, Oosterhuis D, Groothuis GMM, et al. Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs. Toxicol Appl Pharmacol. 2014;274(2):328–338.
  • Van De Bovenkamp M, Groothuis GMM, Meijer DKF, et al. Liver fibrosis in vitro: cell culture models and precision-cut liver slices. Toxicol Vitro. 2007;21(4):545–557.
  • Oenema TA, Maarsingh H, Smit M, et al. Bronchoconstriction induces TGF-β release and airway remodelling in guinea pig lung slices. Plos One. 2013;8(6):e65580.
  • Schlepütz M, Rieg AD, Seehase S, et al. Neurally mediated airway constriction in human and other species: a comparative study using precision-cut lung slices (PCLS). Plos One. 2012;7(10):e47344.
  • Lavoie TL, Krishnan R, Siegel HR, et al. Dilatation of the constricted human airway by tidal expansion of lung parenchyma. Am J Respir Crit Care Med. 2012;186(3):225–232.
  • Groothuis GMM, Casini A, Meurs H, et al. Chapter 3 translational research in pharmacology and toxicology using precision-cut tissue slices [Internet]. In: Coleman R, editor. Human-based systems for translational research. London: The Royal Society of Chemistry; 2015. p. 38–65. http://pubs.rsc.org/en/content/ebook/978-1-84973-825-5#!divbookcontent
  • Fisher RL, Vickers AEM. Preparation and culture of precision-cut organ slices from human and animal. Xenobiotica. 2013;43(1):8–14.
  • De Kanter R, Tuin A, Van De Kerkhof E, et al. A new technique for preparing precision-cut slices from small intestine and colon for drug biotransformation studies. J Pharmacol Toxicol Methods. 2005;51(1):65–72.
  • Vickers AEM, Zollinger M, Dannecker R, et al. In vitro metabolism of tegaserod in human liver and intestine: assessment of drug interactions. Drug Metab Dispos. 2001;29(10):1269–1276.
  • Malfatti MA, Connors MS, Mauthe RJ, et al. The capability of rat colon tissue slices to metabolize the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res. 1996;56(11):2550–2555.
  • De Kanter R, De Jager MH, Draaisma AL, et al. Drug-metabolizing activity of human and rat liver, lung, kidney and intestine slices. Xenobiotica. 2002;32(5):349–362.
  • Lerche-Langrand C, Toutain HJ. Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology. 2000;153(1–3):221–253.
  • De Kanter R, Monshouwer M, Meijer DK, et al. Precision-cut organ slices as a tool to study toxicity and metabolism of xenobiotics with special reference to non-hepatic tissues. Curr Drug Metab. 2002 Feb;3(1):39–59.
  • Van De Kerkhof EG, Ungell A-LB, Sjöberg ÅK, et al. Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with ussing chamber preparations. Drug Metab Dispos. 2006;34(11):1893–1902.
  • Van De Kerkhof EG, de Graaf IAM, Ungell A-LB, et al. Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro. Drug Metab Dispos. 2008;36(3):604–613.
  • Punyadarsaniya D, Winter C, Mork A-K, et al. Precision-cut intestinal slices as a culture system to analyze the infection of differentiated intestinal epithelial cells by avian influenza viruses. J Virol Methods. 2015;212:71–75.
  • de Graaf IAM, Olinga P, De Jager MH, et al. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat Protoc. 2010;5(9):1540–1551.
  • Brouwer KLR, Keppler D, Hoffmaster KA, et al. In vitro methods to support transporter evaluation in drug discovery and development. Clin Pharmacol Ther. 2013;94(1):95–112.
  • Kis O, Zastre J, Hoque MT, et al. Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions. Pharm Res. 2013;30(4):1050–1064.
  • Rozehnal V, Nakai D, Hoepner U, et al. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs. Eur J Pharm Sci. 2012;46(5):367–373.
  • Ellis LCJ, Hawksworth GM, Weaver RJ. ATP-dependent transport of statins by human and rat MRP2/Mrp2. Toxicol Appl Pharmacol. 2013;269(2):187–194.
  • Li M, Si L, Pan H, et al. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int J Pharm. 2011;403(1–2):37–45.
  • The International Transporter Consortium. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9(3):215–236.
  • Hu M, Ling J, Lin H, et al. Use of caco-2 cell monolayers to study drug absorption and metabolism. In: Yan Z, Caldwell G, editors. Optimization in drug discovery. New York: Humana Press; 2004. p. 19–35.
  • Kamiyama E, Sugiyama D, Nakai D, et al. Culture period-dependent change of function and expression of ATP-binding cassette transporters in caco-2 cells. Drug Metab Dispos. 2009;37(9):1956–1962.
  • Siissalo S, Zhang H, Stilgenbauer E, et al. The expression of most udp-glucuronosyltransferases (UGTs) is increased significantly during caco-2 cell differentiation, whereas UGT1A6 is highly expressed also in undifferentiated cells. Drug Metab Dispos. 2008;36(11):2331–2336.
  • Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche. Nature. 2009;459(7244):262–265.
  • Pham BT, Van Haaften WT, Oosterhuis D, et al. Precision-cut rat, mouse, and human intestinal slices as novel models for the early-onset of intestinal fibrosis. Physiol Rep. 2015;3(4):e12323.
  • Russell WMS, Burch RL The principles of humane experimental technique. Hertfordshire: Universities Federation for Animal Welfare Wheathampstead. 1959.
  • Van Der Logt EMJ, Blokzijl T, Van Der Meer R, et al. Westernized high-fat diet accelerates weight loss in dextran sulfate sodium-induced colitis in mice, which is further aggravated by supplementation of heme. J Nutr Biochem. 2013;24(6):1159–1165.
  • Wang WP, Guo X, Koo MWL, et al. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol. 2001 Aug;281(2):G586–G594.
  • Bertrand B, Stefan L, Pirrotta M, et al. Caffeine-based gold(I) N-heterocyclic carbenes as possible anticancer agents: synthesis and biological properties. Inorg Chem. 2014;53(4):2296–2303.
  • De Kanter R, Monshouwer M, Draaisma AL, et al. Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon. Xenobiotica. 2004;34(3):229–241.
  • Martignoni M, Groothuis GM, De Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol. 2006;2(6):875–894.
  • Van De Kerkhof EG, de Graaf IA, Groothuis GM. In vitro methods to study intestinal drug metabolism. Curr Drug Metab. 2007;8(7):658–675.
  • Van Midwoud PM, Merema MT, Verpoorte E, et al. A microfluidic approach for in vitro assessment of interorgan interactions in drug metabolism using intestinal and liver slices. Lab Chip. 2010;10(20):2778–2786.
  • Li M, Si LQ, Pan HP, et al. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int J Pharm. 2011;403(12):37–45.
  • Parsa A, Saadati R, Abbasian Z, et al. Enhanced permeability of etoposide across everted sacs of rat small intestine by vitamin E-TPGS. Iran J Pharm Res. 2013; Winter 12(Suppl):37–46.
  • Van De Kerkhof EG, de Graaf IAM, De Jager MH, et al. Induction of phase I and II drug metabolism in rat small intestine and colon in vitro. Drug Metab Dispos. 2007;35(6):898–907.
  • Van De Kerkhof EG, de Graaf IAM, De Jager MH, et al. Characterization of rat small intestinal and colon precision-cut slices as an in vitro system for drug metabolism and induction studies. Drug Metab Dispos. 2005;33(11):1613–1620.
  • Roskott AM, Nieuwenhuijs VB, Leuvenink HG, et al. Reduced ischemia-reoxygenation injury in rat intestine after luminal preservation with a tailored solution. Transplantation. 2010;90(6):622–629.
  • Li M, de Graaf IAM, De Jager MH, et al. Rat precision-cut intestinal slices to study P-gp activity and the potency of its inhibitors ex vivo. Toxicol Vitro. 2015;29(5):1070–1078.
  • Possidente M, Dragoni S, Franco G, et al. Rat intestinal precision-cut slices as an in vitro model to study xenobiotic interaction with transporters. Eur J Pharmaceutics Biopharmaceutics. 2011;79(2):343–348.
  • Khan AA, Chow ECY, Porte RJ, et al. Expression and regulation of the bile acid transporter, OSTα-OSTβ in rat and human intestine and liver. Biopharm Drug Dispos. 2009;30(5):241–258.
  • Khan AA, Chow ECY, Van Loenen-Weemaes A-M, et al. Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver. Eur J Pharm Sci. 2009;37(2):115–125.
  • Khan AA, Dragt BS, Porte RJ, et al. Regulation of VDR expression in rat and human intestine and liver – consequences for CYP3A expression. Toxicol Vitro. 2010;24(3):822–829.
  • Khan AA, Chow ECY, Porte RJ, et al. The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices. Toxicol Vitro. 2011;25(1):80–90.
  • Niu X. Precision-cut intestinal slices as an ex vivo model to study NSAID-induced intestinal toxicity (chapter 6). Groningen: University of Groningen; 2014.
  • Takano M, Yumoto R, Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol Ther. 2006;109(1–2):137–161.
  • MacLean C, Moenning U, Reichel A, et al. Closing the gaps: A full scan of the intestinal expression of P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats. Drug Metab Dispos. 2008;36(7):1249–1254.
  • Sekine S, Ito K, Saeki J, et al. Interaction of Mrp2 with radixin causes reversible canalicular Mrp2 localization induced by intracellular redox status. Biochimica Biophysica Acta (BBA) Molecular Basis Disease. 2011;1812(11):1427–1434.
  • Knutson T, Fridblom P, Ahlström H, et al. Increased understanding of intestinal drug permeability determined by the LOC-I-GUT approach using multislice computed tomography. Mol Pharm. 2009;6(1):2–10.
  • Fisher MB, Labissiere G. The role of the intestine in drug metabolism and pharmacokinetics: an industry perspective. Curr Drug Metab. 2007 Oct;8(7):694–699.
  • Laffont CM, Toutain P-L, Alvinerie M, et al. Intestinal secretion is a major route for parent ivermectin elimination in the rat. Drug Metab Dispos. 2002;30(6):626–630.
  • Chosidow O, Delchier J-C, Chaumette M-T, et al. Intestinal involvement in drug-induced toxic epidermal necrolysis. The Lancet. 1991;337(8746):928.
  • Niu X, De Graaf IAM, Groothuis GMM. Evaluation of the intestinal toxicity and transport of xenobiotics utilizing precision-cut slices. Xenobiotica. 2013;43(1):73–83.
  • Li M, Vokral I, de Graaf IAM, et al. Precision-cut intestinal slices as ex vivo model to study the uptake of bile acids by ASBT in the intestine. ISSX Online Abstracts 2015;10(Suppl 1):37.
  • Drozdzik M, Gröer C, Penski J, et al. Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine. Mol Pharm. 2014;11(10):3547–3555.
  • Sugimoto H, Hirabayashi H, Kimura Y, et al. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats. Drug Metab Dispos. 2011;39(1):8–14.
  • Li M, de Graaf I, De Jager M, et al. Human PCIS as ex vivo model to study the interplay between P-gp and CYP3A4 in the intestine. ISSX Online Abstracts. 2014;2(Supplement 9):P268.
  • Niu X, de Graaf IAM, Van Der Bij HA, et al. Precision cut intestinal slices are an appropriate ex vivo model to study NSAID-induced intestinal toxicity in rats. Toxicol Vitro. 2014;28(7):1296–1305.
  • Niu X, De Graaf IAM, Van De Vegte D, et al. Consequences of Mrp2 deficiency for diclofenac toxicity in the rat intestine ex vivo. Toxicol Vitro. 2015;29(1):168–175.
  • Niu X, de Graaf IM, Langelaar-Makkinje M, et al. Diclofenac toxicity in human intestine ex vivo is not related to the formation of intestinal metabolites. Arch Toxicol. 2015;89(1):107–119.
  • Siissalo S, De Waard H, De Jager MH, et al. Nanoparticle formulation of a poorly soluble cannabinoid receptor 1 antagonist improves absorption by rat and human intestine. Drug Metab Dispos. 2013 Aug 1;41(8):1557–1565
  • Benet LZ. The drug transporter-metabolism alliance: uncovering and defining the interplay. Mol Pharm. 2009;6(6):1631–1643.
  • Chassany O, Michaux A, Bergmann J. Drug-induced diarrhoea. Drug-Safety. 2000;22(1):53–72.
  • Graham DY, Opekun AR, Willingham FF, et al. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005;3(1):55–59.
  • Maiden L, Thjodleifsson B, Theodors A, et al. A quantitative analysis of nsaid-induced small bowel pathology by capsule enteroscopy. Gastroenterology. 2005;128(5):1172–1178.
  • Lim YJ, Yang C-H. Non-steroidal anti-inflammatory drug-induced enteropathy. Clin Endosc. 2012;45(2):138–144.
  • De Kanter R. Human and rat organ slices: a tool to study drug metabolism and toxicity. Groningen: University of Groningen; 2002.
  • Zusman I, Zimber A. Ultrastructural changes in rat colorectal epithelium and tumors after treatment with N-methyl-N’-nitro-N-nitrosoguanidine and secondary bile acids. Acta Anat. 1991;141(3):282–288.
  • Van Haaften WT, Pham BT, Oosterhuis D, et al. Tu1238 fibrotic human precision-cut intestinal slices: a new ex vivo model for established intestinal fibrosis. Gastroenterology. 2014;146(5, Supplement 1):S791.
  • Trapecar M, Goropevsek A, Gorenjak M, et al. A co-culture model of the developing small intestine offers new insight in the early immunomodulation of enterocytes and macrophages by Lactobacillus spp. through stat1 and nf-kb p65 translocation. Plos One. 2014;9(1):e86297.
  • Vickers AEM, Fisher RL. Evaluation of drug-induced injury and human response in precision-cut tissue slices. Xenobiotica. 2013;43(1):29–40.
  • Roskott AMC, Nieuwenhuijs VB, Dijkstra G, et al. Small bowel preservation for intestinal transplantation: a review. Transpl Int. 2011;24(2):107–131.
  • Grabinger T, Luks L, Kostadinova F, et al. Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy. Cell Death Dis. 2014;5:e1228.
  • Kent TH, Cardelli RM, Stamler FW. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol. 1969;54(2):237–249.
  • Kim HJ, Ingber DE. Gut-on-a-chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr Biol. 2013;5(9):1130–1140.
  • Kim HJ, Huh D, Hamilton G, et al. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 2012;12(12):2165–2174.